top of page

MENQUADFI SOLUTION FOR INJECTION

Product details

Registration number: SIN16454P

Classification: Prescription Only

Active ingredients:

  • Meningococcal Polysaccharide, Serogroup A (Monovalent Conjugate)
  • Meningococcal Polysaccharide, Serogroup C (Monovalent Conjugate)
  • Meningococcal Polysaccharide, Serogroup W-135 (Monovalent Conjugate)
  • Meningococcal Polysaccharide, Serogroup Y (Monovalent Conjugate)
  • Tetanus Toxoid, Filtered Concentrate (Carrier Protein)

Strength:

  • 10 mcg/ 0.5 mL
  • 10 mcg/ 0.5 mL
  • 10 mcg / 0.5mL
  • 10 mcg/ 0.5 mL
  • 55 mcg/ 0.5 mL

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

ATC code: J07AH08

HSA approval date: 29 March 2022

Manufacturer(s): Sanofi Pasteur, Inc.

Manufacturing country/countries: UNITED STATES

What are the HSA registration number and classification for MENQUADFI SOLUTION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16454P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for MENQUADFI SOLUTION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Meningococcal Polysaccharide, Serogroup A (Monovalent Conjugate)
  • Meningococcal Polysaccharide, Serogroup C (Monovalent Conjugate)
  • Meningococcal Polysaccharide, Serogroup W-135 (Monovalent Conjugate)
  • Meningococcal Polysaccharide, Serogroup Y (Monovalent Conjugate)
  • Tetanus Toxoid, Filtered Concentrate (Carrier Protein)

Strength:

  • 10 mcg/ 0.5 mL
  • 10 mcg/ 0.5 mL
  • 10 mcg / 0.5mL
  • 10 mcg/ 0.5 mL
  • 55 mcg/ 0.5 mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for MENQUADFI SOLUTION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for MENQUADFI SOLUTION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for MENQUADFI SOLUTION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Sanofi Pasteur, Inc.

Manufacturing country/countries: UNITED STATES

Source for this answer

Where can I look up MENQUADFI SOLUTION FOR INJECTION in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16454P or the exact product name MENQUADFI SOLUTION FOR INJECTION. The general register link does not preselect this product.

Source for this answer

What are the source dates for this MENQUADFI SOLUTION FOR INJECTION record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this MENQUADFI SOLUTION FOR INJECTION record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16454P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page